Guidance on the mutual acceptance of EU Digital COVID Certificates issued to participants of clinical trials for COVID-19 vaccines published by European Commission

Guidance on the mutual acceptance of EU Digital COVID Certificates issued to participants of clinical trials for COVID-19 vaccines
Annex – The report [in the Annex] refers to all trials on COVID-19 Vaccines that NCAs have uploaded in EudraCT. Trials for which information cannot be shared are marked in yellow and are here anonymised, leaving only information on the EU/EEA countries were the trial is planned to be run. Those are trials for which an authorisation from the National Competent Authority and or the Ethics Committee is awaited, or they are approved phase 1 trials conducted solely in adults.